Name | Zelminemab |
---|
Description | Zelminemab (AMG-301) is a human monoclonal antibody that inhibits PACAP type I (PAC1) receptor[1]. |
---|---|
Related Catalog | |
In Vivo | Zelminemab(10 mg/kg;i.v.;一次)降低 TCC 中的伤害性神经元活动[2]。 Animal Model: Sprague-Dawley rats, electricalstimulation was performed on the intact dura mater abovethe middle meningeal artery[2]. Dosage: 10 mg/kg Administration: i.v.; once Result: Induced an inhibition of stimulus-evoked nociceptive activity in the trigeminocervical com-plex (TCC). |
References |
No Any Chemical & Physical Properties |